Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Sildenafil Citrate Orodispersible Tablets

Approval Number

国药准字H20254049

Company恒昌（广州）新药研究有限公司

Registration Date

April 30, 2025

Drug Information

Generic Name

枸橼酸西地那非口崩片

Dosage Form

片剂

Strength

50mg（按C₂₂H₃₀N₆O₄S计）

Drug Type

化学药品

Registration Date

April 30, 2025

Company Information

Applicant Company

Company Name恒昌（广州）新药研究有限公司

Company Address

广东省广州市黄埔区神舟路288号C栋1001房

Manufacturing Company

Company Name武汉海特生物制药股份有限公司

Company Address

湖北省武汉经济技术开发区海特科技园

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy